U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07558967) titled 'Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects' on April 19.
Brief Summary: This study evaluated the bioequivalence and safety of the test formulation (Tenofovir Disoproxil Fumarate Tablets, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (Viread(R), Gilead Sciences, Inc.) in healthy Chinese subjects under fasting and fed conditions
Study Start Date: June 20, 2017
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Test Tenofovir Disoproxil Fumarate Tablets
Test formulation（Tenofovir Disoproxil Fumarate Tablets，Haisco Pharmaceutical Grou...